Clinical trial
Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
NCT00113698 · University of Utah, Other · Terminated
Key facts
| NCT number | NCT00113698 |
|---|---|
| Title | Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation |
| Official title | Trial of ACE Inhibition in Children With Mitral Regurgitation After Repair of AVSD |
| Acronym | AceiMR |
| Lead sponsor | University of Utah, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Pediatric Heart Network |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Defects, Congenital, Heart Septal Defects, Ventricular, Heart Failure, Congestive |
| Intervention type | Drug, Other |
| Interventions | Enalapril, Placebo |
| Enrollment | 5 |
| Start date | Dec 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Jun 10, 2005 |
| Last update posted | Mar 13, 2014 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: